JP2009503093A5 - - Google Patents

Download PDF

Info

Publication number
JP2009503093A5
JP2009503093A5 JP2008525132A JP2008525132A JP2009503093A5 JP 2009503093 A5 JP2009503093 A5 JP 2009503093A5 JP 2008525132 A JP2008525132 A JP 2008525132A JP 2008525132 A JP2008525132 A JP 2008525132A JP 2009503093 A5 JP2009503093 A5 JP 2009503093A5
Authority
JP
Japan
Prior art keywords
insulin
composition
patient
dose
administered
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008525132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009503093A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/030014 external-priority patent/WO2007016600A2/en
Publication of JP2009503093A publication Critical patent/JP2009503093A/ja
Publication of JP2009503093A5 publication Critical patent/JP2009503093A5/ja
Pending legal-status Critical Current

Links

JP2008525132A 2005-08-01 2006-08-01 インスリン産生細胞の機能を保持する方法 Pending JP2009503093A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70429505P 2005-08-01 2005-08-01
PCT/US2006/030014 WO2007016600A2 (en) 2005-08-01 2006-08-01 Method of preserving the function of insulin-producing cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015002059A Division JP2015091854A (ja) 2005-08-01 2015-01-08 インスリン産生細胞の機能を保持する方法

Publications (2)

Publication Number Publication Date
JP2009503093A JP2009503093A (ja) 2009-01-29
JP2009503093A5 true JP2009503093A5 (https=) 2009-09-03

Family

ID=37561086

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008525132A Pending JP2009503093A (ja) 2005-08-01 2006-08-01 インスリン産生細胞の機能を保持する方法
JP2015002059A Pending JP2015091854A (ja) 2005-08-01 2015-01-08 インスリン産生細胞の機能を保持する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015002059A Pending JP2015091854A (ja) 2005-08-01 2015-01-08 インスリン産生細胞の機能を保持する方法

Country Status (10)

Country Link
EP (1) EP1915171B1 (https=)
JP (2) JP2009503093A (https=)
CN (1) CN101232899A (https=)
AU (1) AU2006275424B2 (https=)
BR (1) BRPI0614489A2 (https=)
CA (1) CA2617226A1 (https=)
DK (1) DK1915171T3 (https=)
ES (1) ES2439455T3 (https=)
MX (1) MX2008001643A (https=)
WO (1) WO2007016600A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
WO2003080149A2 (en) 2002-03-20 2003-10-02 Mannkind Corporation Inhalation apparatus
US9078866B2 (en) * 2003-08-01 2015-07-14 Mannkind Corporation Method for treating hyperglycemia with GLP-1
PL1786784T3 (pl) 2004-08-20 2011-04-29 Mannkind Corp Kataliza syntezy diketopiperazyn
KR101644250B1 (ko) 2004-08-23 2016-07-29 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh) 2005-09-14 2018-04-24 曼金德公司 以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
IN2015DN00888A (https=) 2006-02-22 2015-07-10 Mannkind Corp
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
ES2929343T3 (es) 2008-06-13 2022-11-28 Mannkind Corp Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko) 2008-06-20 2016-06-08 맨카인드 코포레이션 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
MX2011009251A (es) * 2009-03-04 2011-11-18 Mannkind Corp Sistema mejorado de suministro de farmaco en polvo seco.
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
CN104721825B (zh) 2009-06-12 2019-04-12 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
IL223742A (en) 2010-06-21 2016-06-30 Mannkind Corp A dry powder inhaler and preparation for it
AU2012236150B2 (en) 2011-04-01 2016-03-31 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
BR112014009686A2 (pt) 2011-10-24 2018-08-07 Mannkind Corp composição analgésica inalável, pó seco e método para tratar dor
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
AU2014228415B2 (en) 2013-03-15 2018-08-09 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
MX375448B (es) 2013-07-18 2025-03-06 Mannkind Corp Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
AU2015339576B2 (en) 2014-10-27 2020-02-06 Glytec, Llc Subcutaneous outpatient management
JP7109155B2 (ja) 2015-06-04 2022-07-29 キッコーマン株式会社 フラビン結合型グルコースデヒドロゲナーゼを用いたグルコースの測定方法
WO2017031440A1 (en) 2015-08-20 2017-02-23 Aseko, Inc. Diabetes management therapy advisor
CN110187123B (zh) * 2019-05-06 2022-07-22 天津医科大学总医院 一种糖尿病早期诊断生物标志物及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2285457A1 (en) * 1997-04-02 1998-10-08 Hoshi University Method for oral delivery of proteins
DK1808438T3 (da) * 1999-06-29 2014-10-27 Mannkind Corp Rensning og stabilisering af peptid og proteiner i lægemidler
GB0217382D0 (en) * 2002-07-26 2002-09-04 Pfizer Ltd Process for making orally consumable dosage forms
EP1605895A4 (en) * 2003-03-06 2011-08-24 Emisphere Tech Inc ORAL INSULIN THERAPIES AND PROTOCOL
NZ548980A (en) * 2004-01-12 2009-10-30 Mannkind Corp Reducing serum proinsulin levels in type 2 diabetics

Similar Documents

Publication Publication Date Title
JP2009503093A5 (https=)
US20240181019A1 (en) Use of ultrarapid acting insulin
AU2016228157B2 (en) Use of ultrarapid acting insulin
AU2006275424B2 (en) Method of preserving the function of insulin-producing cells
US20250064898A1 (en) Insulin glargine/lixisenatide fixed ratio formulation
JP5788374B2 (ja) 糖尿病治療における優れた血糖コントロール
CN101027082A (zh) 降低2型糖尿病患者血清胰岛素原水平的方法
JP2007517892A5 (https=)
Evans et al. Recent developments and emerging therapies for type 2 diabetes mellitus
JP2020510628A5 (https=)
US20240342251A1 (en) Method of treating hypoglycemia events in diabetes treatment
JP2020502151A5 (https=)
AU2013204281C1 (en) Use of ultrarapid acting insulin
CN116018156A (zh) 使用人类胰淀素类似物多肽对1型糖尿病患者提供卓越的血糖控制
HK1242994A1 (en) Use of ultrarapid acting insulin
HK1242994B (en) Use of ultrarapid acting insulin